Navipharm Private Limited
About Navipharm Private Limited
Data last updated:
Navipharm Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24248TG2015PTC100765. Its GSTIN is 36AAFCN0463J1ZF (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Venkatasubbarao Potluri and Ratna Rao Vissa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.26 Cr, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹97.76 Lakh (net margin 43.3%) and EBITDA of ₹1.3 Cr (EBITDA margin 57.8%). Revenue has grown at a compounded annual rate (CAGR) of 536% over three years and 2% over five years.
Its group structure includes 1 subsidiary.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Navipharm Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressH.No.4 – 50/48/2 Plot No.58 Regency Classic 2nd Floor, Jayabheri Enclave Gachibowli, Hyderabad, Telangana, India – 500032
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Navipharm Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Navipharm is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Navipharm Private Limited, buy the company report.
Financials of Navipharm Private Limited
FY 2025 filings availableNavipharm Private Limited reported revenue of ₹2.26 Cr (up 49% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 49% growth in the latest year. EBITDA rose 118% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.3 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹97.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 57.8% | ||||
| Net Profit Margin | 43.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Navipharm Private Limited, buy the company report.
Board of directors of Navipharm Private Limited
Navipharm has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rangaswamy Srinivasa Raghavan Gandarvakottai Also directs: Ingrela Products Private Limited | Additional Director | 13 Dec 2021 | 4 Years 10 Months | Current |
| Venkatasubbarao Potluri Also directs: Revive Impex Private Limited, Arbor Life Sciences Private Limited | Director | 15 Sep 2015 | 11 Years 1 Months | Current |
| Ratna Rao Vissa Also directs: Revive Impex Private Limited, Arbor Life Sciences Private Limited | Director | 15 Sep 2015 | 11 Years 1 Months | Current |
Auditor
Navipharm Private Limited is audited by K S S GANGADHAR & CO for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K S S GANGADHAR & CO | FY 2016 | 008692S |
Shareholding
The shareholding of Navipharm Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Navipharm Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Navipharm Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Navipharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Navipharm has 1 subsidiary company. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Selectchemie Services Private Limited | U74999TG2016PTC112710 |
To see the full group structure of Navipharm Private Limited, buy the company report.
GST
Navipharm has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCN0463J1ZF | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Navipharm Private Limited, buy the company report.
Recent activity
Navipharm Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Rangaswamy Srinivasa Raghavan Gandarvakottai was appointed as Additional Director on 13 Dec 2021.
Frequently asked questions
Navipharm is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 September 2015 (11+ years old) and is registered under CIN U24248TG2015PTC100765.
Navipharm has 3 current directors:
- Rangaswamy Srinivasa Raghavan Gandarvakottai - Additional Director
- Venkatasubbarao Potluri - Director
- Ratna Rao Vissa - Director
The latest financial statements of Navipharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Navipharm is 36AAFCN0463J1ZF, registered in Telangana.
The CIN (Corporate Identification Number) of Navipharm is U24248TG2015PTC100765. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Navipharm was incorporated on 15 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Rangaswamy Srinivasa Raghavan Gandarvakottai was appointed as Additional Director on 13 Dec 2021. Rangaswamy Srinivasa Raghavan Gandarvakottai ceased to be Director on 01 Apr 2019. Ratna Rao Vissa was appointed as Director on 15 Sep 2015. Navipharm has 4 board changes on record in total.
The registered office of Navipharm is at H.No.4 – 50482 Plot No.58 Regency Classic 2nd Floor, Jayabheri Enclave Gachibowli, Hyderabad, Telangana, India – 500032.
Navipharm operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Navipharm is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
